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Abstract
Sleep deprivation (SD) is known to induce perceptual impairments, ranging from perceptual distortion
to hallucinatory states. Although this phenomenon has been extensively described in the literature, its
neurobiological underpinnings remain elusive. In rodents, SD induces a series of behavioural patterns that
might be reflective of psychosis and mania, such as hyperlocomotion and sensitization to psychotogenic
drugs. Notably, such changes are accompanied by transitory alterations of dopaminergic signalling. Based
on the hypothesis that both psychotic and manic disorders reflect gating impairments, the present study
was aimed at the assessment of the impact of SD on the behavioural model of prepulse inhibition (PPI) of
the startle reflex, a reliable paradigm for the study of informational filtering. Rats subjected to SD (24 h,
48 h, 72 h) exhibited a time-dependent increase in startle reflex and a dramatic deficit in PPI. Both
alterations were reversed 24 h after termination of the SD period. Interestingly, PPI disruption was
efficiently prevented by haloperidol (0.1 mg/kg i.p.) clozapine (5 mg/kg i.p.) and risperidone (1 mg/kg
i.p.). Conversely, neither the anxiolytic diazepam (5 mg/kg i.p.) nor the antidepressant citalopram (5 mg/
kg i.p) affected the PPI disruption mediated by SD, although diazepam reversed the enhancement in
startle reflex magnitude induced by this manipulation. Our data suggest that SD induces gating deficits
that might be relevant to the hallucinatory phenomena observed in humans, and provide a novel reliable
animal model where such relationship can be studied.
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Introduction
Sleep disturbances are a common symptom of psy-
chotic and hallucinatory disorders (Benca et al., 1992 ;
Benson and Zarcone, 1993 ; Keshavan et al., 1990 ;
Monti and Monti, 2004; Onheiber et al., 1965 ; Stern
et al., 1969). For example, schizophrenia patients
exhibit an erratic sleep profile, with hyposomnia and
deficits in both rapid eye movement (REM) and slow-
wave sleep (Lauer et al., 1997 ; Monti and Monti, 2004 ;
Neylan et al., 1992 ; Tandon et al., 1992). The intensity
of such alterations is related to the severity of psy-
chotic symptoms and is attenuated by antipsychotic
therapy (Keshavan et al., 1995 ; Monti andMonti, 2004 ;
Tandon et al., 1992 ; Taylor et al., 1992 ; Thaker et al.,
1990 ; van Kammen et al., 1988). Mounting evidence
suggests that alterations of sleep architecture might
precipitate the neurobiological imbalances underlying
psychotic disorders. In particular, sleep deprivation
(SD) is conducive to several abnormalities, ranging
from minor disturbances and abnormal bodily sen-
sations to disturbances reminiscent of those observed
in schizophrenia patients, including disorganized
thought, depersonalization, complex acoustic and
visual hallucinations, with changes in dimensional
perception as well as loss of insight. Notably, this
array of symptoms is typically reversed following a
prolonged, restorative sleep (Tyler, 1955).
Similarly, rodents forced to prolonged SD exhibit
a spectrum of manic-like and psychotic-like behav-
ioural responses, such as hyperactivity, increased
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responsiveness to psychostimulants, irritability, ag-
gressiveness and perseverative behaviours (Gessa
et al., 1995). This evidence suggests that the neuro-
biological alterations induced by SD might partially
mimic the pathogenesis of psychotic and hallucinatory
states. Current views posit that such phenomena may
result from impairments of gating function, which
would lead to an altered sensitivity to sensory stimuli,
perceptual overload and cognitive fragmentation
(Braff et al., 2001).
The best validated paradigm to evaluate and
measure sensorimotor gating is the prepulse inhibition
(PPI) of the acoustic startle reflex (ASR), consisting in
the reduction of the ASR that occurs when the eliciting
stimulus is immediately preceded by a non-startling
prestimulus (Graham, 1975). PPI is typically impaired
in several neuropsychiatric disorders characterized
by attentional or somatosensory deficits (Braff et al.,
2001), such as psychotic disorders (Braff et al., 1999)
and mania (Perry et al., 2001 ; Saccuzzo and Braff,
1986). Alterations in PPI can also be induced in
animals by psychotomimetic drugs and selectively
reversed by antipsychotic agents (Braff et al., 2001),
lending further support to the validity of PPI as a
model of psychosis. In light of these premises, we
designed the present study to characterize the effects
of SD on startle reflex and PPI in rats.
Specifically, throughout this study rats were sleep-
deprived with the platform method (Jouvet et al.,
1964). In this paradigm, the muscle atonia which ac-
companies REM sleep, causes the animal to fall into
the water and wake up. Thus, this procedure produces
a complete reduction of REM sleep (Kovalzon and
Tsibulsky, 1984).
Method
Animals
A total of 138 male Sprague–Dawley albino rats
[Harlan, S. Pietro al Natsione (UD), Italy] weighing
between 200 g and 300 g served as subjects in the
present study. Rats were housed four per cage in the
animal care quarters, maintained at a temperature of
22¡2 xC on a reversed 12-h light–dark cycle (lights on
19:00 hours). Food and water were available ad libi-
tum, and each rat was handled for 5 min on each of the
5 d prior to experiment to minimize stress effects. All
experimental procedures were approved by the ethical
committee of the University of Cagliari and carried out
in strict accordance with the Economic Community
(EC) guidelines for the care and use of experimental
animals (86/609/European EC).
Drugs and chemicals
The following drugs were used in the study: halo-
peridol (Hal), clozapine (Clo), risperidone (Ris),
diazepam (Diaz) and citalopram (Cit). All drugs were
purchased from Sigma Aldrich (Milan, Italy). Hal was
dissolved in 10% acetic acid buffered (to pH 7.0) with
sodium hydroxide (NaOH) and diluted with saline,
while Clo was dissolved in a single drop of 1 N
hydrogen chloride (HCl) and diluted with saline. The
pH was adjusted to 7 using sodium bicarbonate
(NaHCO3). Ris and Diaz were dissolved in 0.9% saline
solution, with 0.3% Tween-80. Citalopram hydro-
bromide and nicotine were dissolved in 0.9% saline
solution. All drugs were weighed out as salts and
administered i.p. in an injection volume of 2 ml/kg.
Apparatus
The apparatus for the detection of the startle reflexes
(Med Associates, St Albans, VT, USA) consisted of
four standard cages placed in sound-attenuated
chambers with fan ventilation. The cage was a
Plexiglas cylinder of 9 cm diameter, mounted on a
piezoelectric accelerometric platform connected to an
analogue digital converter. Background noise and
acoustic bursts were conveyed by two separate
speakers, placed close to the startle cage so as to pro-
duce a variation of sound within 1 dB across it. Both
speakers and startle cages were connected to a main
personal computer (PC), which detected and analysed
all chamber variables by means of custom software.
Acoustic stimuli were monitored and balanced before
each testing session through a digital sound level
meter (Extech Instruments, Waltham, MA, USA),
while the mechanical response of each cage was set
and equalized in all chambers via a 10-Hz spinner
calibrator provided by Med Associates.
Procedure
Three days before the experiment, all rats went
through a brief baseline startle session. Rats were
exposed to a background noise of 70 dB, and after an
acclimatization period of 5 min, they were presented
with a randomized sequence of 12–40 ms bursts of
115 dB, interposed with three trials in which an 82-dB
prestimulus preceded the same pulse by 100 ms.
Rats exhibiting very high or very low baseline
startle values (>2 S.D. above or below group mean
values) were excluded from the study. Subsequently,
treatment groups were established so that the average
startle response and percent PPI of each group were
equivalent in all groups.
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For SD, rats were kept on a small Plexiglas platform
(7 cm in diameter) within a deep tank filled with
water. Each platform was surrounded by water up to
1 cm, beneath the surface. Food and water were freely
available by placing chow pellets and water bottles on
a grid located on the top of the tank. During the whole
SD study, the temperatures of the experimental room
and the water inside the tank were maintained at
23¡1 xC. Control rats were placed in the experimental
room, either in their home cages or on water tanks
equivalent to those used for SD, but with a 12 cm-
diameter platform, which allowed them to reach REM
sleep without falling into the water.
At the end of the SD period, rats were immediately
dried out and then placed in a startle cage for a 5-min
acclimatization period with a 70 dB white-noise back-
ground, which continued for the remainder of the
session. Each session consisted of three consecutive
sequences of trials (periods). Unlike the first and
the third periods, during which rats were presented
with only five pulse-alone trials of 115 dB, the second
period consisted of a pseudo-random sequence of 50
trials, including 12 pulse-alone trials ; 30 trials of pulse
preceded by prepulses of 73 dB, 76 dB, or 82 dB
(10 for each level of prepulse loudness) ; and eight
no-stimulus trials, where only the background noise
was delivered. Inter-trial intervals (ITI) were selected
randomly between 10 s and 15 s. Each startle session
lasted about 30 min. The study consisted of five
experiments, summarized in Table 1 with the time-
intervals for each treatment in all the experiments.
Experiment description
This study was articulated in four series of exper-
iments. In the first experiment (n=45 rats, 15 rats/
group) we evaluated if SD could affect startle and
PPI parameters. Thus, 45 rats were tested and then
divided into three equivalent groups (15 rats/group).
The first group was subjected to SD with the narrow-
platform technique. Rats in the second group were
kept in identical SD cages, but with larger platforms,
which allowed them to sleep. The third group in-
cluded home-caged rats in the housing room, where
light and temperature were kept in identical con-
ditions as the experimental room. The experiment
lasted 72 h, since this duration has been shown to
produce the most remarkable behavioural changes in
rats (Fratta et al., 1987).
Following the discovery that SD enhances startle
reaction and disrupts PPI, we tested whether this
effect could depend on the stress induced by soaking
in water. A group of home-caged, single-housed rats
(n=8) were placed directly inside the water in SD
tanks for six times at variable intervals over 72 h
(the average number of lapses into water during a SD
session, as assessed during preliminary observations).
Rats were removed from the tanks and relocated in
their home cages (without bedding) only after they
climbed back on top of the narrow platforms. The
last soaking episode always occurred 1 h before PPI
testing. Rats were dried only immediately before
PPI session, but not throughout the 72-h soaking
procedure. As controls, we used rats housed singly in
home cages deprived of bedding for 72 h (n=10).
In a third experiment, we studied whether the
SD-induced PPI alteration was time-dependent and
reversible. Then, 15 rats were tested at the beginning
of SD and every 24 h for the following 3 d. After the
last testing (at 72 h), rats were immediately returned to
their home cages and re-tested after 24 h.
The following series of three experiments (n=60,
10 animals/group) was carried out to verify whether
SD-induced PPI disruption could be reversed by
the antipsychotic agents Hal (0.1 mg/kg i.p), Clo
(5 mg/kg i.p.) and Ris (1 mg/kg i.p.), in comparison
to their vehicles. All antipsychotic compounds (or
their vehicle) were injected 1 h before the end of SD
(71 h).
In the last phase of the study (n=30, 7–8 animals/
group) we verified whether SD-mediated PPI deficits
by SD could also be related to anxiety or mood dis-
turbances. Hence, rats received an injection of the
anxiolytic drug Diaz (5 mg/kg i.p.), the potent anti-
depressant Cit (5 mg/kg i.p.) or their vehicles 30 min
before the conclusion of SD.
Rats used in the first two experiments were naive
to any previous treatment or environmental manipu-
lation. To minimize the number of the rats used, con-
trol rats in the first experiment were re-used for the
fourth series of experiments, after 10–14 d.
Table 1. Startle magnitudes in rats subjected to sleep
deprivation for 72 h, in comparison to controls placed in
water tanks with large platforms and in their home cages
Experimental
condition
Startle
amplitude
Sleep deprivation 752¡36
Large platform 586¡35*
Home cage 641¡43
Values represent mean¡S.E.M. for each treatment.
* p<0.05 in comparison to sleep-deprived rats. (For further
details, see text.)
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Data analysis
For each animal, the mean startle amplitudes for
the first and the second halves of the second period
of the session (blocks, six pulse-alone trials each)
were analysed with a two-way or three-way analysis
of variance (ANOVA), with pretreatment (where
present) and treatment as between-subjects factors
and blocks as repeated measures. The percent PPI was
calculated with the following formula :
100x
MSA for prepulse-pulse trials
MSA for pulse-alone trials
 .
100,
where MSA=mean startle amplitude, and analysed
in multifactor ANOVAs (with specific design and
comparisons noted below for each experiment) with
the different combinations of injections for pretreat-
ment and treatment as between-subjects factors and
trial types as repeated measures. Post-hoc analyses
were performed using Tukey’s test. Throughout the
study, no significant interaction between prepulse
levels and pharmacological treatment has been found:
thus, the PPI values have been collapsed to represent
average PPI. Alpha was set at 0.05.
Results
Effects of SD
The first experiment evaluated rats before and after
72 h of platform SD, in comparison with two control
groups : home-caged rats and animals placed for the
same duration of time inside the deprivation tanks on
large platforms (where they were able to sleep). The
analysis of startle amplitude was performed by one-
way ANOVA (Table 1). A main effect was detected
[F(2, 42)=4.84, p<0.05]. Of note, Tukey’s test revealed
that this effect was due to a significant difference
between sleep-deprived rats and control rats on
the large platforms (p<0.05). The difference between
home-caged rats and sleep-deprived rats, however,
was not fully significant (p<0.10).
A two-way, repeated-measure ANOVA was carried
out to test PPI values. The analysis confirmed main
effects for both the environmental manipulations
[F(2, 42)=21.47, p<0.001] and the prepulse levels
[F(2, 84)=20.26, p<0.001], but did not detect any
interaction between the two factors [F(4, 84)=0.71,
n.s.]. Post-hoc comparisons revealed that SD produced
a significant deficit in PPI in comparison to both con-
trol groups (p<0.001 for both comparisons, Tukey’s
test) (Figure 1).
In the second experiment, we tested the effects of
repeated soaking over 72 h on startle and PPI. As
shown in Figure 2, soaked rats displayed a lower
startle amplitude than controls (Figure 2a) [F(1, 16)=
4.55, p<0.05]. PPI analysis, performed by two-way
ANOVA (with treatment and PPI levels as factors)
found no significant difference between rats subjected
to repeated soaking and controls [F(1, 16)=0.46, n.s.]
(Figure 2b). Although a significant effect was found
for prepulse levels [F(2, 32)=13.51, p<0.001], the
analysis revealed no significant treatmentrprepulse
level interaction [F(2, 32)=1.72, n.s.].
The third experiment was aimed at assessing the
effects of SD on startle reflex and PPI, at different time-
intervals during SD (0, 24, 48, 72 h), as well as 24 h
after termination of the procedure. Startle magnitudes
were evaluated using a one-way ANOVA, with time
as factor. As shown in Figure 3a, statistical analysis
revealed that rats exhibited a significant, time-
dependent increase of startle reflex [F(4, 70)=9.21,
p<0.001 ; p<0.05 for comparison between 0 h and
48 h; p<0.01 for comparison between 0 h and 72 h;
Tukey’s test], which was reversed after 24 h from the
end of SD (p<0.01 for comparison between 72 h
and 96 h, Tukey’s test). The subsequent statistical
analysis on PPI values, performed via a two-way
ANOVA – with time and prepulse levels as factors –
detected that SD reduced PPI [main effect : F(4, 70)=
10.69, p<0.001]. Post-hoc analysis confirmed that
72 h SD produced a significant PPI deficit (p<0.001
in comparison with baseline values, Tukey’s test).
(Figure 3b) while rats exhibited PPI values similar to
the baseline after 24 h (n.s. in comparison with base-
line values). Finally, a main effect was also found for
prepulse levels [F(2, 140)=21.47, p<0.001], but no
interaction between the two factors was present
[F(8, 140)=0.64, n.s.].
100
75
50
%
 P
P
I
25
0
Home-caged Large platform Sleep deprivation
***+++
PP3
PP6
PP12
Figure 1. Effects of sleep deprivation on prepulse inhibition
(PPI), compared to controls placed in water tanks with large
platforms and in their home cages. Values represent
mean¡S.E.M. for each treatment. Prepulses (PP3, PP6, PP12)
are indicated by the intensity corresponding to decibels
above background noise. *** p<0.001 compared to home-
caged rats ; +++ p<0.001 compared to rats placed in water
tanks with a large platform. (For further details, see text.)
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Effects of antipsychotic treatments on SD-mediated
PPI deficit
We addressed the next series of experiments to
the assessment of the ability of three benchmark anti-
psychotics, Hal (0.1 mg/kg i.p.), Clo (5 mg/kg i.p.)
and Ris (5 mg/kg i.p.), in comparison to their
respective vehicles, to counter the PPI disruption pro-
duced by 72 h SD. Startle amplitudes were analysed
by a one-way ANOVA, followed by Tukey’s test
(Table 2).
Hal did not significantly reverse the increase in
startle, although ANOVA showed a statistical trend
[F(1, 18)=2.94, p<0.01]. Conversely, it did reverse the
PPI deficit [F(1, 18)=8.75, p<0.01] (Figure 4a). Clo
antagonized the effects of SD on both startle amplitude
[F(1, 18)=41.26, p<0.001] and PPI [F(1, 18)=29.43,
p<0.01] (Figure 4b). Ris induced similar effects (Startle
[F(1, 18)=10.24, p<0.01] ; PPI [F(1, 18)=6.42, p<0.05])
(Figure 4c). For all three experiments, ANOVA
detected a main effect for prepulse levels (Hal
[F(2, 36)=7.40, p<0.01] ; Clo [F(2, 36)=4.40, p<0.05] ;
Ris [F(2, 36)=3.92, p<0.05]). However, no interactions
between treatment and prepulse levels were identified
(data not shown).
Effects of Diaz and Cit on SD-mediated PPI deficit
Since SD has been shown to induce a number of dis-
turbances of mood and anxiety, the fourth experiment
was aimed at evaluating the specific predictive
value of SD-induced PPI impairment as a model of
gating impairment relevant to psychotic and manic
phenomena. To this end, we tested whether either the
anxiolytic Diaz (5 mg/kg i.p.) or the antidepressant
Cit (5 mg/kg i.p.) could reverse the changes induced
by SD, compared to their vehicles. Startle magnitudes
were evaluated with the same statistical design as in
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Figure 3. Time-dependent effects of sleep deprivation (SD) on (a) startle and (b) prepulse inhibition (PPI). Values represent
mean¡S.E.M. for each treatment. Prepulses (PP3, PP6, PP12) are indicated by the intensity corresponding to decibels above
background noise. * p<0.05, ** p<0.01 in comparison to baseline values immediately before the beginning of SD (0 h) ; ## p<0.01
in comparison to values relative to 72 h of SD. Rec, recovery. (For further details, see text.)
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Figure 2. Effects of repeated soaking on (a) startle amplitude and (b) prepulse inhibition (PPI), compared to home-caged
controls. Values represent mean¡S.E.M. for each treatment. Prepulses (PP3, PP6, PP12) are indicated by the intensity
corresponding to decibels above background noise. * p<0.05 compared to control rats. (For further details, see text.)
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the previous experiment. ANOVA showed that
Diaz significantly reduced startle reflex [F(1, 13)=6.77,
p<0.05] (Table 3). A subsequent ANOVA to test PPI
values yielded a significant effect for prepulse level
[F(2, 26)=9.95, p<0.01], but not for either treatment
[F(2, 26)=0.01, n.s.] or treatmentrprepulse level
interaction [F(2, 26)=0.30, n.s.] (Figure 4d).
A parallel analysis for Cit revealed that this anti-
depressant did not alter either startle magnitude
[F(1, 13)=0.11, n.s.] or PPI [F(1, 13)=0.11, n.s.] in
SD-subjected rats. Of interest, no fully significant effect
was found for prepulse levels [F(2, 26)=2.57, p<0.10]
or treatmentrprepulse level interaction [F(2, 26)=
3.16, p<0.10] (Figure 4e).
Discussion
The present study shows that, in rats, SD leads to a
progressive, time-dependent increase in ASR and
PPI deficit. Specifically, the enhancement of startle
response is already significant at 48 h SD, while
disruption of the gating functions reaches full sig-
nificance after 72 h of the same procedure. Both
impairments are completely reversed 24 h after
SD discontinuation. Furthermore, our experiments
strongly suggest that these deficits are specifically
dependent on SD, and do not reflect the environmen-
tal stress associated with the manipulation used in the
experiment, as indicated by the phenomenological
dissociation between the effects of repeated soaking
and SD in analogous experimental conditions.
These findings indicate that REM SD leads to a
progressive reduction of informational filtering func-
tions. This decrement, signified by the PPI reduction,
is theorized to initiate hallucinatory phenomena by
saturating the physiological capability of the brain to
process external and internal information. This possi-
bility is consistent with previous evidence showing
that SD induces hallucinations, perceptual distortions
and psychotic-like reactions in humans (Tyler, 1955).
Table 2. Effects of antipsychotic drugs on startle
amplitudes of sleep-deprived rats
Treatment
Startle
amplitude
Vehicle 688¡54
Haloperidol (0.1 mg/kg i.p.) 552¡57
Vehicle 774¡53
Clozapine (5 mg/kg i.p.) 363¡34***
Vehicle 801¡66
Risperidone (1 mg/kg i.p.) 529¡52*
Values represent mean¡S.E.M. for each treatment.
* p<0.05, *** p<0.001 in comparison to vehicle-treated rats.
(For further details, see text.)
Table 3. Effects of diazepam and citalopram on
startle amplitudes of sleep-deprived rats
Treatment
Startle
amplitude
Vehicle 840¡91
Diazepam (5 mg/kg i.p.) 535¡74*
Vehicle 924¡76
Citalopram (5 mg/kg i.p.) 823¡73
Values represent mean¡S.E.M. for each treatment. (For
further details, see text.)
* p<0.05 in comparison to vehicle-treated rats. (For further
details, see text.)
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Figure 4. Effects of (a) haloperidol (Hal, 0.1 mg/kg i.p.) ; (b) clozapine (Clo, 0.1 mg/kg i.p.) ; (c) risperidone (Ris, 1 mg/kg i.p.) ;
(d) diazepam (Diaz, 5 mg/kg i.p.) ; (e) citalopram (Cit, 5 mg/kg i.p.) on the prepulse inhibition (PPI) disruption induced by
sleep deprivation (72 h), in comparison to their respective vehicles (Veh). PPI data represent the average of PPI produced by the
three different prepulse intensities. Values represent mean¡S.E.M. for each treatment. * p<0.05, ** p<0.01, *** p<0.001 in
comparison to Veh. (For further details, see text.)
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While impairments in sleep architecture may
contribute to the pathophysiological processes of psy-
chosis, the relationship between sleep disturbances
and psychotic symptoms has been shown to be bi-
directional. Schizophrenia patients display an erratic
polysomnographic profile, with deficits in REM and
non-REM phases, which become particularly remark-
able during exacerbations and relapses of the syn-
drome (Benca et al., 1992 ; Lauer et al., 1997 ; Monti and
Monti, 2004; Tandon et al., 1992). In particular, REM
parameters are correlated to the severity of all major
clusters of schizophrenia, and antipsychotics prolong
REM latency in schizophrenia patients (Benson and
Zarcone, 1993 ; Monti and Monti, 2004 ; Taylor et al.,
1992 ; Thaker et al., 1990).
The role of REM sleep in the modulation of gating
mechanisms is poorly understood. Although PPI is not
affected by either brainstem lesions producing REM
sleep (Wu et al., 1990) sensory gating is abnormal
during this stage (van Luijtelaar et al., 1998). An in-
triguing possibility is that intrusion or leakage of REM
sleep events into waking may contribute to the gating
impairments following prolonged SD. Accordingly,
a similar process has been shown to underlie pre-
attentional and attentional disorders in schizophrenia
(Zarcone et al., 1969), as well as the psychotic mani-
festations in narcolepsy (Walterfang et al., 2005).
Both gating functions and REM sleep are regulated
by the pedunculopontine nucleus (PPN). Indeed,
physiological modifications of REM sleep have been
indicated to alter gating through modifications in the
PPN cholinergic system (Kobayashi et al., 2004).
Furthermore, alterations in quality and duration of
REM sleep in schizophrenia have been shown to re-
flect changes in responsiveness of PPN neurons (Rye,
1997).
The present study has shown that the effects of SD
on sensorimotor gating have been completely sup-
pressed by pretreatment with three benchmark anti-
psychotic drugs, such as Hal, Clo and Ris. Of note, Clo
induced a remarkable reduction of startle amplitude,
which may partially account for the effects in PPI.
Nevertheless, this possibility is tempered by previous
findings from our group, showing that the reductions
in startle magnitude induced by Clo are never
paralleled by significant changes in baseline PPI in our
experimental conditions (Bortolato et al., 2005 ; Frau
et al., 2007).
Since the main mechanism of action shared by these
drugs is the blockade of D2 dopamine receptors, our
results suggest that these receptors may be directly
involved in the SD-induced disruption of sensori-
motor gating. SD induces a significant up-regulation
of D2 receptors in the nucleus accumbens and caudate
putamen, in a fashion similar to that observed in
schizophrenia patients (Abi-Dargham et al., 2000 ;
Farde et al., 1990 ; Nunes Junior et al., 1994). Notably,
both brain regions have been directly implicated in the
dopaminergic regulation of PPI (Swerdlow et al., 2001)
and in psychotic symptoms. Interestingly, SD has also
been shown to enhance the responsiveness of rats to
dopaminergic agonists, such as apomorphine (Tufik,
1981 ; Tufik et al., 1978), which are known to produce
a dramatic deficit of sensorimotor gating and PPI
(Mansbach et al., 1988). Interestingly, apomorphine
and selective D2 receptor agonists reduce REM sleep
(Cianchetti et al., 1980 ; Monti et al., 1988), and dopa-
mine transmission is generally believed to govern
the balance between wakefulness and sleepiness
(Wisor et al., 2001).
Other non-dopaminergic alterations may also be
partially responsible for the gating deficits induced by
SD. For example, this manipulation induces alter-
ations of serotonergic signalling (Salomon et al., 1994)
and glutamate N-methyl-D-aspartate (NMDA) recep-
tor expression (McDermott et al., 2006), which may in
turn lead to deficits in gating and PPI.
Besides its specific action on SD the platform
method causes heavy stress to the rat, due to several
factors such as isolation, falling into the water, soaking
and others. Indeed, anxiety and stress are known to
magnify many of the behavioural effects of SD (Tyler,
1955). In the present study, SD also produces an
increase of startle reflex in a fashion responsive to the
potent anxiolytic Diaz, suggesting the ability of SD to
increase emotional reactivity (Ogilvie and Broughton,
1976). However, Diaz did not affect PPI parameters.
This interesting premise supports the possibility that
anxiogenic and psychotomimetic effects of SD reflect
distinct neurobiological mechanisms.
Notably, neither startle increases nor gating deficits
were reversed by the potent antidepressant Cit, lend-
ing support to the specificity of the neurobiological
substrates underpinning both alterations.
PPI deficits become significant after 72 h of SD,
in concomitance with other manifestations, such as
hyperactivity, irritability, aggressiveness, hypersexu-
ality and stereotyped behaviour (Fratta et al., 1987).
Our study confirms previous studies interpreting this
behavioural spectrum as an animal model of mania
(Gessa et al., 1995), since the latter is also associated
with gating deficits (Franks et al., 1983). Based on our
results, SD-induced PPI disruption may also be a
novel paradigm for the study of the connections
between sleep and integrity of reflex and cognitive
mechanisms. Finally, it could also be proposed as an
Sleep deprivation and PPI of startle response 953
animal model of psychosis, by virtue of its face, con-
struct and predictive validity – shown by its sensi-
tivity to antipsychotics, but not other categories of
psychotropic drugs. Nevertheless, future studies are
certainly warranted to assess the heuristic value, the
significance and the relevance of this paradigm to
psychotic phenomena.
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